167 related articles for article (PubMed ID: 22485218)
1. Magnetic resonance imaging of endothelial cells with vectorized iron oxide nanoparticles.
Abakumov MA; Goldt AE; Sokolsky-Papkov M; Zorkina YA; Baklaushev VP; Goodilin EA; Kabanov AV; Chekhonin VP
Bull Exp Biol Med; 2011 Oct; 151(6):726-30. PubMed ID: 22485218
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific contrast agent based on ferric oxide superparamagnetic nanoparticles for visualization of gliomas by magnetic resonance tomography.
Abakumov MA; Grinenko NF; Baklaushev VP; Sandalova TO; Nukolova NV; Semyonova AV; Sokol'ski-Papkov M; Vishvasrao H; Kabanov AV; Chekhonin VP
Bull Exp Biol Med; 2012 May; 153(1):89-93. PubMed ID: 22808502
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
Zeng L; Ren W; Zheng J; Cui P; Wu A
Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
[TBL] [Abstract][Full Text] [Related]
4. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
Tähkä S; Laiho A; Kostiainen MA
Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron-iron oxide nanoparticles.
Miguel OB; Gossuin Y; Morales MP; Gillis P; Muller RN; Veintemillas-Verdaguer S
Magn Reson Imaging; 2007 Dec; 25(10):1437-41. PubMed ID: 17566686
[TBL] [Abstract][Full Text] [Related]
6. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
[TBL] [Abstract][Full Text] [Related]
7. Catechol derivatives-coated Fe3O4 and gamma-Fe2O3 nanoparticles as potential MRI contrast agents.
Basti H; Ben Tahar L; Smiri LS; Herbst F; Vaulay MJ; Chau F; Ammar S; Benderbous S
J Colloid Interface Sci; 2010 Jan; 341(2):248-54. PubMed ID: 19853857
[TBL] [Abstract][Full Text] [Related]
8. Hot-injection synthesis of iron/iron oxide core/shell nanoparticles for T2 contrast enhancement in magnetic resonance imaging.
Herman DA; Ferguson P; Cheong S; Hermans IF; Ruck BJ; Allan KM; Prabakar S; Spencer JL; Lendrum CD; Tilley RD
Chem Commun (Camb); 2011 Aug; 47(32):9221-3. PubMed ID: 21761066
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic Fe3O4 Nanoparticles: Synthesis by Thermal Decomposition of Iron(III) Glucuronate and Application in Magnetic Resonance Imaging.
Patsula V; Kosinová L; Lovrić M; Ferhatovic Hamzić L; Rabyk M; Konefal R; Paruzel A; Šlouf M; Herynek V; Gajović S; Horák D
ACS Appl Mater Interfaces; 2016 Mar; 8(11):7238-47. PubMed ID: 26928653
[TBL] [Abstract][Full Text] [Related]
10. Surface functionalization of magnetic iron oxide nanoparticles for MRI applications - effect of anchoring group and ligand exchange protocol.
Smolensky ED; Park HY; Berquó TS; Pierre VC
Contrast Media Mol Imaging; 2011; 6(4):189-99. PubMed ID: 21861279
[TBL] [Abstract][Full Text] [Related]
11. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
[TBL] [Abstract][Full Text] [Related]
12. Relaxation Properties of Contrast Media for MRI Based on Iron Oxide Nanoparticles in Different Magnetic Fields.
Chekhonin VP; Abakumov MA; Mazhuga AG; Bagdinova AN; Demikhov EI; Demikhov TE; Mishkinis BY; Konstantinov MV; Tarasov VP; Shumm BA; Gippius AA; Gervits NV; Shumm AB
Bull Exp Biol Med; 2019 May; 167(1):97-99. PubMed ID: 31183644
[TBL] [Abstract][Full Text] [Related]
13. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
[TBL] [Abstract][Full Text] [Related]
14. Hydrothermal synthesis of a highly sensitive T2-weigthed MRI contrast agent: zinc-doped superparamagnetic iron oxide nanocrystals.
Chen F; Bu W; Lu C; Chen G; Chen M; Shen X; Liu R; Shi J
J Nanosci Nanotechnol; 2011 Dec; 11(12):10438-43. PubMed ID: 22408922
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
Ma HL; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2007 Mar; 333(1-2):177-86. PubMed ID: 17074454
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
[TBL] [Abstract][Full Text] [Related]
17. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent.
Nitin N; LaConte LE; Zurkiya O; Hu X; Bao G
J Biol Inorg Chem; 2004 Sep; 9(6):706-12. PubMed ID: 15232722
[TBL] [Abstract][Full Text] [Related]
18. Characterization of superparamagnetic iron oxide coated with silicone used as contrast agent for magnetic resonance image for the gastrointestinal tract.
Gamarra LF; Mamani JB; Carneiro SM; Fabris JD; Ferreira RV; Domingues RZ; Cornejo DR; Pontuschka WM; Amaro EJ
J Nanosci Nanotechnol; 2010 Feb; 10(2):1153-8. PubMed ID: 20352771
[TBL] [Abstract][Full Text] [Related]
19. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Gold-Coated Iron Oxide Nanoparticles as Negative T2 Contrast Agent in Small Animal MRI Studies.
Iancu SD; Albu C; Chiriac L; Moldovan R; Stefancu A; Moisoiu V; Coman V; Szabo L; Leopold N; Bálint Z
Int J Nanomedicine; 2020; 15():4811-4824. PubMed ID: 32753867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
